May. 22 at 12:20 AM
$NSPR wicked to
$0.9800 and recovered above
$1.00 on 2.4x average volume. InspireMD. CGuard Prime carotid stent. FDA approved. US launch underway. Descending channel lower line holding. RSI making higher lows while price makes lower lows — divergence confirmed.
🐂
$1.00 holds and
$1.20 midline next. US revenue quarter is the catalyst that changes everything.
🐻
$1.00 loses and channel breakdown.
$0.9800 broken = delisting risk territory.
⚠️ RSI divergence. 2.4x volume.
$1.00 wick recovered. Channel lower line decision right now.
📊 Lean: MILD BULL — divergence plus volume at the channel floor. CGuard data is real — commercialization is the only missing piece.
#NSPR #InspireMD #MedicalDevice #hovdid
